-
21.02.2019
"Excellent Communications Design-Brand Identity" award for STIRIXIS Group
This time…an international branding recognition -
19.02.2019
-
19.02.2019
Novartis receives FDA approval for Egaten®
For the treatment of fascioliasis, a neglected tropical disease -
19.02.2019
Beiersdorf: Successful Business Year 2018
Beiersdorf continued on its growth path in the 2018 financial year -
18.02.2019
AbbVie: A strategic transaction to develop a New Treatment for Multiple Myeloma
In collaboration with Teneobio, Inc - MORE
.jpg){kind=logo}
.jpg){kind=logo}
1.jpg){kind=logo}
.jpg){kind=logo}
1.jpg)
1.jpg)
1.jpg){kind=logo}
1.jpg){kind=logo}
.jpg)
.jpg)
